Actively Recruiting
The Effectiveness of the Quadro-Iliac Plane Block in Hip Arthroplasty: A Prospective Observational Clinical Study
Led by San Giovanni di Dio Hospital · Updated on 2026-05-22
80
Participants Needed
2
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand how different locoregional anesthesia techniques affect recovery and pain control after hip replacement surgery. It focuses especially on the Quadro-Iliac Plane (QIP) block, a newer method used during hip arthroplasty. The study compares QIP to other common anesthesia methods to see if it improves patients' postoperative recovery and pain management. Participants undergoing hip replacement as part of their usual care will receive one of several anesthesia techniques chosen by their anesthesiologist, which may include QIP block, fascia iliaca block, PENG block, or others. All blocks are performed using ultrasound guidance and standard safety procedures. The study is observational, so no treatments are assigned by the researchers. The planned participation period covers the hospital stay and up to 7 days after surgery for safety monitoring. Patients will be assessed for quality of recovery 24 hours after surgery using the QoR-15 score. Additional measures include pain levels at rest and during movement up to 48 hours, total pain medication used, time to first pain medication request, time to first mobilization, and any complications or side effects from anesthesia. Safety monitoring includes checking for immediate and delayed anesthesia-related issues up to one week post-surgery. The study expects to enroll 40 to 80 patients over about 18 months.
CONDITIONS
Brief Title
The Quadro-Iliac Plane (QIP) Block in Hip Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Undergoing hip arthroplasty surgery, either elective or for a proximal femoral fracture
- Expected postoperative hospital stay of at least 24 hours
- ASA physical status I to III
- Receiving neuraxial and/or locoregional anesthesia as part of standard care
- Provided informed consent to participate in the study
You will not qualify if you...
- No informed consent given
- Contraindications to locoregional and/or spinal anesthesia
- Allergy to local anesthetic agents
- Cognitive impairment preventing reliable outcome assessment
- Coagulation disorders or platelet abnormalities
- Antiplatelet or anticoagulant therapy that prevents spinal anesthesia
- Localized infection or sepsis at anesthesia sites
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 48 hours after surgery
Participants undergo hip arthroplasty surgery with locoregional anesthesia techniques as part of routine clinical practice. Immediate recovery and analgesic outcomes are monitored.
Assessments at 0, 2, 4, 6, 8, 12, 24, and 48 hours after surgery
Duration - Up to 7 days after surgery
Participants are observed for safety monitoring including block-related or postoperative adverse events, and delayed neurological symptoms.
Approximately 2 follow-up assessments within 7 days post-surgery
Trial Site Locations
Total: 2 locations
1
Crotone Hospital
Crotone, Italy
Actively Recruiting
2
Crotone Hospital
Crotone, Italy
Actively Recruiting
Research Team
T
Tommaso Sorrentino, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here